Biovie INC.
SEC CIK 1580149 · bivi · last insider filing 2026-01-09
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Rogich Sigmund | Director | filed 2020 - 2026 |
| Do Cuong V | Director · President & CEO | filed 2018 - 2026 |
| Lang James Paul | Director | filed 2018 - 2026 |
| Sherman Michael Edward | Director | filed 2018 - 2026 |
| Chappell Amy Suzon | Director | filed 2025 - 2026 |
| Farag Kameel D. | Director | filed 2025 - 2026 |
| Berman Richard J | Director | filed 2021 - 2025 |
| Hariri Robert J | Director | filed 2021 - 2025 |
| Gorlin Steve | Director | filed 2020 - 2023 |
| Peizer Terren S | Director | filed 2022 - 2023 |
| Adams Jonathan M | Director · chief operating officer | filed 2018 - 2022 |
| Wieland R Richard | Director · interim CFO | filed 2018 - 2020 |
| Anderson Julie G | Director | filed 2018 - 2020 |
| Kumar Hari | Director | filed 2019 - 2020 |
| Sooch Mina | Director | filed 2018 - 2020 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| KIM Joanne Wendy | Chief Financial officer | filed 2019 - 2026 |
| Palumbo Joseph M | Chief Medical Officer | filed 2021 - 2026 |
| Reading Christopher | EVP Neuroscience R&D | filed 2021 - 2023 |
| Markham Penelope | EVP Liver Cirrhosis R&D | filed 2019 - 2023 |
| Ahlem Clarence N. | EVP of Product Development | filed 2021 - 2023 |
| Yeramian Patrick D | Chief Medical Officer | filed 2019 - 2020 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.